Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
AUTOTAC Bio Logo
AUTOTAC Bio Growth Score
67
CB Rank
105968
Heat Score
59
AUTOTAC Bio is a drug development company that creates protein target decomposition drugs for humans.
Founded
obfuscation
PrivateSeries B Seoul, Seoul-t'ukpyolsi, South Korea11-50 www.autotacbio.com
Biotechnology
Health Care
Pharmaceutical
Overview

AUTOTAC Bio
Total Funding
obfuscation
Growth Score
67
Heat Score
59

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score67
-4 pts
in past quarter
Heat Score 59
-19 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About AUTOTAC Bio

CB Rank
105968
AUTOTAC Bio is a drug development company that creates protein target decomposition drugs for humans.
Founded
obfuscation
PrivateSeries B Seoul, Seoul-t'ukpyolsi, South Korea11-50 www.autotacbio.com
Biotechnology
Health Care
Pharmaceutical

Funding Rounds

Series B
OBF
in
obfuscation

Details

Legal Name AUTOTAC Bio Inc.
Operating Status Active
Company Type For Profit
Phone Number +82 02 6951 1448
Contact Email admin@autotacbio.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AUTOTAC Technology
A platform technology that targets and breaks down disease-causing proteins using the autophagy-lysosome system.
Alzheimer's Disease Treatment
AUTOTACs selectively sequester tau aggregates and target them to the lysosome for autophagic degradation to treat Alzheimer's disease.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
3
obfuscation
— Series B
obfuscation
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
3
obfuscation
— Series B
obfuscation
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
3
obfuscation
— Series B
obfuscation
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
3
obfuscation
— Series B
obfuscation
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
3
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
3
obfuscation
— Series B
obfuscation
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
3
obfuscation
— Series B
obfuscation
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
3
obfuscation
— Series B
obfuscation
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
3
obfuscation
— Series B
obfuscation
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
3
obfuscation
— Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Dayli Partners Logo
Dayli Partners
—
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
—
Dayli Partners Logo
Dayli Partners
—
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
—
Dayli Partners Logo
Dayli Partners
—
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
—
Dayli Partners Logo
Dayli Partners
—
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
—
Dayli Partners Logo
Dayli Partners
—
Series B - AUTOTAC Bio Logo
Series B - AUTOTAC Bio
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News

News and Press

News•Dec 10, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

54

Active Website Tech Count

9AUTOTAC Bio is actively using 9 technologies for its website, according to BuiltWith. These include SSL by Default, Apple Mobile Web Clips Icon, and  SPF.

Total IP

1AUTOTAC Bio has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is AUTOTAC Bio's headquarters? AUTOTAC Bio is located in Seoul, Seoul-t'ukpyolsi, South Korea.Who invested in AUTOTAC Bio? AUTOTAC Bio has 3 investors including Dayli Partners and  Shinhan Venture Investment.When was the last funding round for AUTOTAC Bio? AUTOTAC Bio closed its last funding round on
obfuscation
from a Series B round.Who are AUTOTAC Bio's competitors? Alternatives and possible competitors to AUTOTAC Bio may include Nurix Therapeutics, Monte Rosa Therapeutics, and  Arvinas.How much funding has AUTOTAC Bio raised to date? AUTOTAC Bio has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(250d0b0 1)
|